You just read:

Regeneron and Bayer Initiate Phase 3 Trial of EYLEA® (aflibercept) Injection for the Treatment of Diabetic Macular Edema in Asia and Russia

News provided by

Regeneron Pharmaceuticals, Inc.

Feb 19, 2013, 02:30 EST